Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'mcl1 in 1'

Search results for: 'mcl1 in 1'

Items 1-10 of 44

Page
per page
  1. PP 1
    A8215 PP 1
    Target: Src|EGFR|JAK|ZAP-70
    Summary: Src family tyrosine kinase inhibitor
  2. IRAK-1-4 Inhibitor I
    A3505 IRAK-1-4 Inhibitor I
     3 Citation
    Target: IRAK
    Summary: IRAK-1/4 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.75 mg/mL
  3. LRRK2-IN-1
    A3558 LRRK2-IN-1
     1 Citation
    Target: LRRK2|DCLK2
    Summary: LRRK2 inhibitor,cell-permeable and ATP competitive
      ≥28.55 mg/mL
  4. DMH-1
    B3686 DMH-1
    Target: BMP and Other Activin Receptors
    Summary: Selective BMP ALK2 receptor
      insoluble in H2O; insoluble in EtOH; ≥9.51 mg/mL
  5. IRAK inhibitor 1
    A3500 IRAK inhibitor 1
     2 Citation
    Target: IRAK
    Summary: IRAK-4 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.4 mg/mL
  6. 1-NM-PP1
    B1299 1-NM-PP1
    Target: Cyclin-Dependent Kinases|Bcr-Abl|Src|Ca2 /calmodulin-dependent protein kinases (CaMKs)|c-Fyn
    Summary: Pp60c-src inhibitor
      insoluble in H2O; ≥16.55 mg/mL
  7. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL
  8. Motesanib
    A3632 Motesanib
    Target: VEGFR
    Summary: Inhibitor of Flk-1/Flt-4/PDGFR-/c-Kit
      ≥42 mg/mL
  9. CP-673451
    B2173 CP-673451
    Target: PDGFR
    Summary: PDGFRα/β inhibitor,potent and selective
  10. Quizartinib (AC220)
    A5793 Quizartinib (AC220)
    Target: FLT3
    Summary: FLT3 inhibitor,potent and selective
      ≥28.03 mg/mL

Items 1-10 of 44

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 1 item
  2. Axl 1 item
  3. ALK 3item
  4. c-FMS 1 item
  5. c-Kit 1 item
  6. c-MET 2item
  7. c-RET 2item
  8. CSF-1R 1 item
  9. EGFR 1 item
  10. FGFR 3item
  11. FLT3 4item
  12. HER2 1 item
  13. IGF1R 2item
  14. IRAK 2item
  15. ITK 1 item
  16. LRRK2 2item
  17. PDGFR 6item
  18. Spleen Tyrosine Kinase (Syk) 3item
  19. Src 2item
  20. Tie-2 2item
  21. Trk 1 item
  22. VEGFR 14item
Reversibility
  1. Reversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 3item
  3. Aurora Kinases 1 item
  4. CSF-1R 1 item
  5. FLT3 6item
  6. VEGFR 17item
  7. PDGFR 9item
  8. c-Kit 4item
  9. RET 2item
  10. IRAK 2item
  11. Bcr-Abl 4item
  12. FGFR 3item
  13. Insulin-like growth factor receptors(IGFRs) 1 item
  14. MET 1 item
  15. Src 4item
  16. Trk Receptors 2item
  17. EGFR 2item
  18. BMP and Other Activin Receptors 1 item
  19. JAK 1 item
  20. Syk 3item
  21. c-MET 3item
  22. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  23. LRRK2 2item
  24. Insulin and Insulin-like Receptors 1 item
  25. ALK 1 item
  26. Tie-2 2item
  27. Ron 1 item
  28. c-Fyn 1 item
  29. Insulin Receptors 1 item
  30. IRG-1R 1 item
  31. ZAP-70 1 item
  32. c-Fms tyrosine kinase 1 item
  33. ITK 1 item
  34. DCLK2 1 item
Reported Experiments
  1. Animal Experiments 40item
  2. Cell Experiments 25item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Autoimmune Diseases 1 item
  5. Bladder Cancer 2item
  6. Breast Cancer 9item
  7. Cancer 27item
  8. Cervical Cancer 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 1 item
  11. Colon Carcinoma 3item
  12. Colorectal Cancer 8item
  13. Glioblastoma 3item
  14. Glioma 1 item
  15. Leukemia 1 item
  16. Liver Cancer 1 item
  17. Lung Cancer 4item
  18. Lung Carcinoma 2item
  19. Lymphoma 2item
  20. Melanoma 1 item
  21. Multiple Myeloma 2item
  22. Myeloma 1 item
  23. Non-small Cell Lung Cancer 3item
  24. Ovarian Cancer 3item
  25. Pancreatic Cancer 2item
  26. Prostate Cancer 3item
  27. Pulmonary Arterial Hypertension 1 item
  28. Renal Cancer 2item
  29. Renal Cell Carcinoma 2item
  30. Thyroid Cancer 3item